Your diversified EIS portfolio

Fund Twenty8 is no longer open to new investments. Please visit our Access EIS Fund page if you wish to make an investment.

Fund Twenty8 follows the decisions of sophisticated private and professional investors to automatically build you a diversified portfolio of no fewer than 28 EIS-qualifying startups.

The fund’s strategy is based on extensive research conducted by NESTA and Intelligent Partnership, which asked the question: how many startup investments should I have?

The magic number appears to be: no fewer than 28. With this many startups in your portfolio, the study suggests a 95% chance of at least one giving you a return of 10X or more. With this in mind, the fund is targeting a return of over 20% IRR, including up to 30% EIS tax relief.


Independent review

Fund Twenty8 received an independent review from MJ Hudson Allenbridge, a leading independent investment advisory and investment research group, providing independent advice, due diligence and analytical solutions to help institutional investors make better investment decisions.

This independent review has not been commissioned by SyndicateRoom. It has not been issued or approved by SyndicateRoom. It is not a recommendation to invest and does not constitute advice.

Our portfolio

While traditional EIS funds normally invest in just a few companies, covering limited sectors, Fund Twenty8 backs a minimum of 28 per fund, per year, offering truly sector-agnostic diversification.

Having just finished deploying its second fund, Fund Twenty8 has:

  • 426 investors
  • Invested a total of £8.54m
  • Diversified over 64 investments
  • Across 13 sectors

Portfolio breakdown

Review

I’ve been investing in individual companies and have built up a sizeable portfolio, but I’d not invested in EIS funds until I discovered Fund Twenty8.

The focus on diversification makes a lot of sense to me and I think that using the personal investment decisions of numerous savvy investors to deploy capital is a very clever model.

Suraj Rajan

Fund Twenty8 investor

Investment strategy

Invest alongside lead investors

Mitigate risk by building a sector-agnostic and diversified portfolio across no fewer than 28 Qualifying Investments

Target development capital in companies that are:

  • Ideally in revenue, which can provide shorter times to exit
  • Usually pre-profit
  • Able to demonstrate strong and established management teams with proven business credentials
  • Aiming to generate an IRR of 20% or more (inc EIS)
  • EIS eligible at the time of investment and the Manager will seek to retain EIS eligibility as appropriate

"> PORTFOLIO BREAKDOWN

By following the investment decisions of some of the savviest private investors, Fund Twenty8 automatically builds you a diversified portfolio of no fewer than 28 EIS-qualifying startups. The portfolio of every iteration of Fund Twenty8 will be added to this page as they finish deploying.


Fund Twenty8-2017 portfolio

Fund Twenty8's 2017 portfolio consists of 32 investments spanning ten sectors. As our portfolio grows and raises further capital, we look forward to seeing its companies succeed.

Download portfolio brochure


FUND TWENTY8-2017 PORTFOLIO COMPANIES

bockatech

Bockatech
ENGINEERING

interpac

Interpac
ENGINEERING

greenspur

Greenspur Renewables
ENVIRONMENT

naked-energy

Naked Energy
ENVIRONMENT

Pass the Keys

Pass the Keys
MARKETPLACES

pekama

Pekama
MARKETPLACES

luckytrip

LuckyTrip
MARKETPLACES

ambicare

Ambicare
LIFE SCIENCES

arcis biotechnology

Arcis Biotechnology
LIFE SCIENCES

cipher surgical

Cipher Surgical
LIFE SCIENCES

enterobiotix

EnteroBiotix
LIFE SCIENCES

Gemetix Healthcare

Gemetix Healthcare
LIFE SCIENCES

Molecular Warehouse

Molecular Warehouse
LIFE SCIENCES

MGB Biopharma

MGB Biopharma
LIFE SCIENCES

Metrion Biosciences

Metrion Biosciences
LIFE SCIENCES

Lightpoint Medical

Lightpoint Medical
LIFE SCIENCES

PatientSource

PatientSource
LIFE SCIENCES

Pertinax Pharma

Pertinax Pharma
LIFE SCIENCES

Supapass

Supapass
MEDIA

NextUp Comedy

NextUp Comedy
MEDIA

AskIf

AskIf
FINANCIAL

Cambscuisine

Cambscuisine
OTHER

Cyance

Cyance
SOFTWARE

Driftrock

Driftrock
SOFTWARE

Liopa

Liopa
SOFTWARE

Measurematch

Measurematch
SOFTWARE

infloAi

infloAi
SOFTWARE

Kulea

Kulea
SOFTWARE

Sensize

Sensize
SOFTWARE

2Mee

2Mee
SOFTWARE

Mayku

Mayku
TECH

Mimica

Mimica
TECH

Fund Twenty8-2016 portfolio

The first Fund Twenty8 closed in 2017 and finished deploying in 2018. By September, the portfolio was valued at 108% (paper value). Its final portfolio is a testament to the fund's mission: to deliver investors a large and diversified portfolio of at least 28 investments.

  • 233 investors took part
  • Invested a total of £4.55m
  • Diversified over 32 investments
  • Across 10 sectors

Portfolio breakdown (PDF)


FUND TWENTY8-2016 PORTFOLIO COMPANIES

Dymag

Dymag
ENGINEERING

Alert Technology

Alert Technology
ENVIRONMENT

USIO

USIO
ENVIRONMENT

Pekama

Pekama
MARKETPLACES

Starstock

Starstock
MARKETPLACES

Celame

Celame
MARKETPLACES

Biotechspert

Biotechspert
MARKETPLACES

Make it Social

Make it Social
MARKETPLACES

e-Patient Network

e-Patient Network
HEALTHCARE

Dem DX

Dem DX
HEALTHCARE

Emoquo

Emoquo
HEALTHCARE

SupaPass

SupaPass
MEDIA

Peptinnovate

Peptinnovate
PHARMA

Re-Vana Therapeutics

Re-Vana Therapeutics
PHARMA

Digital Therapeutics

Digital Therapeutics
PHARMA

Camallergy

Camallergy
PHARMA

Momentum Bioscience

Momentum Bioscience
PHARMA

FutureYou

FutureYou
PHARMA

Metrion Biosciences

Metrion Biosciences
PHARMA

Arcis

Arcis
PHARMA

Redecol

Redecol
MEDTECH

Warwick Analytics

Warwick Analytics
SOFTWARE

Articheck

Articheck
SOFTWARE

Brytlyt

Brytlyt
SOFTWARE

Fantoo

Fantoo
SOFTWARE

10to8

10to8
SOFTWARE

Cyance

Cyance
SOFTWARE

TenderSpace

TenderSpace
SOFTWARE

Warwick Audio

Warwick Audio
TECH

Freedom One

Freedom One
TECH

Shields Energy

Shields Energy
TECH

Engenie

Engenie
TRANSPORT